The Journal of Organic Chemistry
■ EXPERIMENTAL SECTION
Article
dried NMR tube equipped with a septum was charged with 1-CBT (10
mg, 0.078 mmol, 1.2 equiv) and 1,2,4,5-C H Cl (10.2 mg). The tube
was then purged with Ar through a needle. Deuterochloroform (600
μL) was added via syringe, and then the tube was agitated with a
vortex mixer. Acid 8 (12.1 mg, 0.066 mmol) was added as a solid, and
then the tube was agitated with a vortex mixer. A solution of
6
2
4
(
DHQD) PHAL (5.0 mg in 50 μL of CDCl 0.0065 mmol, 0.1 equiv)
2
3
,
was added via syringe, and then the tube was agitated with a vortex
mixer. The reaction mixture was analyzed by H NMR spectroscopy
after 1 and 24 h. After 24 h, a solution of butyl vinyl ether in ethanol
Chlorolactonization of 8 with DCDMH in the Presence of 1
equiv of Quinuclidine. Preparation of rel-(5R,6S)-5-Chlorote-
trahydro-6-phenyl-2H-pyran-2-one (9). A flame-dried 50 mL
Schlenk flask was charged with quinuclidine (333 mg, 3.00 mmol, 1.00
equiv) and chloroform (15.0 mL, 0.200 M) at room temperature. (E)-
1
(15 vol %, 100 μL) was added to quench the reaction. The resulting
solution was concentrated in vacuo (23 °C, 6 mmHg). The residue
was purified by column chromatography (silica gel, 1 g, 1 cm diam,
CH Cl /hexane, 4:1) to afford 8.8 mg (66%) of 9 as a colorless oil.
5-Phenyl-4-pentenoic acid 8 (529 mg, 3.0 mmol) was added to the
2
2
solution, followed by DCDMH (709 mg, 3.6 mmol, 1.20 equiv), and
the resulting mixture was stirred at room temperature for 3 h. The
reaction was quenched by the addition of a solution of butyl vinyl
ether (388 μL, 300 mg, 3.0 mmol, 1.0 equiv) in ethanol (4.0 mL,
approximately 10% v/v solution). After being stirred for 10 min, the
solution was poured into a separatory funnel, washed with water (2 ×
CSP-SFC: (5R,6S)/(5S,6R)-9, t 7.0 min (45.0%); (5S,6R)/(5R,6S)-9,
R
tR 11.5 min (55.0%) (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in
CO2).
10 mL) and brine (1 × 10 mL), dried over sodium sulfate (4 g),
filtered, and concentrated in vacuo (30 °C, 10 mmHg) to form a thick,
1
yellow oil. Integration of the crude H NMR indicated a mixture of 9
and 24 in a ca. 100:17 ratio. Filtration through a silica plug (4 cm ⌀ ×
10 cm) eluting with dichloromethane provided a white solid that was
subsequently recrystallized from tert-butyl methyl ether to provide 9 as
white needles (398 mg, 63%). Residual TBME incorporated into the
crystalline product can be removed by sublimation of the needles at 60
Preparation of 2,6,7-Triphenylquinuclidines (15 and 19). A
flame-dried, 100 mL, single-neck, round-bottomed flask fitted with a
magnetic stir bar, reflux condenser, and Ar inlet was charged with
bromoamine 18 (879 mg, 2.09 mmol, 1.0 equiv) and dissolved in
toluene (30 mL). To the obtained solution was added sodium
bicarbonate (176 mg, 4.18 mmol, 2.0 equiv), and the reaction mixture
was heated at 115 °C for 12 h. Then the reaction mixture was cooled
to room temperature and quenched with 30 mL of distilled water. The
mixture was transferred to a 125 mL separatory flask, and the aqueous
layer was extracted with dichloromethane (3 × 60 mL). The combined
organic layer was washed with saturated brine solution (1 × 50 mL),
°
C/0.1 mmHg. Purification of the mother liquor by radial silica gel
chromatography (4 mm, 9:1 hexanes/ethyl acetate) provided the
minor isomer 24 as a clear, colorless oil (95.0 mg, 15%). Data for 9:
1
mp (sublim) 99−100 °C; H NMR (500 MHz, CDCl ) δ 7.48−7.34
3
(
m, 3 H, HC(9 and 10)), 7.35−7.29 (m, 2 H, HC(8)), 5.49 (d, J = 5.9
Hz, 1 H, HC(6)), 4.32 (ddd, J = 6.2, 5.9, 4.2 Hz, 1 H, HC(5)), 2.96
ddd, J = 18.2, 9.0, 7.1 Hz, 1 H, HaC(3)), 2.71 (ddd, J = 18.2, 6.5, 5.5
(
Hz, 1 H, HbC(3)), 2.35 (dddd, J = 14.1, 8.9, 6.5, 4.2 Hz, 1 H,
HaC(4)), 2.20 (dddd, J = 14.1, 7.2, 6.3, 5.5, 0.89 Hz, 1 H, HbC(4));
1
3
1
dried over MgSO , and concentrated by rotary evaporation to give the
C{ H} NMR (126 MHz, CDCl ) δ 169.2 (C(2)), 137.1 (C(7)),
4
3
crude mixture of quinuclidines as yellow oil. Purification by flash
1
2
29.2 (C(10)), 129.0 (C(9)), 126.4 (C(8)), 85.4 (C(6)), 56.4 (C(5)),
7.3 (C(3)), 26.8 (C(4)); IR (neat, cm ): 3445 (w), 2963 (w), 1724
−1
chromatography (SiO , 200 mm × 25 mm, 10 mL fractions, hexanes/
2
CH Cl , 4:1 then hexane/EtOAc, 19:1) yielded C -symmetric
(
(
s, CO), 1495 (w), 1458 (w), 1382 (w), 1221 (s), 1066 (m), 1031
2
2
3
+
quinuclidine 15 as a white solid (349 mg, 49%) and C -symmetric
s), 949 (m), 920 (m), 756 (m), 697 (s), 648 (m), 515 (m); MS (EI ,
1
+
37
+
35
quinuclidine 19 as a colorless oil (183 mg, 26%, R 0.39 (hexane/
TOF, 70 eV) 212.1 (22, M , Cl), 210.1 (66, M , Cl), 148.1 (18),
38.0 (10), 120.1 (10), 105.1 (74), 104.0 (100), 91.1 (9), 76.0 (41);
f
1
EtOAc, 19:1) [UV, I ]). The H NMR spectroscopic data matched
those from an alternative preparation. Data for 15: H NMR (500
MHz, CDCl ) δ 7.66 (d, J = 8.2 Hz, 6 H, HC(2)), 7.37 (t, J = 7.7 Hz,
1
2
3
1
1
+
HRMS (EI , TOF) m/z calcd for C H O Cl 210.0448, found
11
11
2
2
10.0446; TLC R 0.24 (hexanes/EtOAc 3:1) [UV, KMnO ]. Anal.
3
f
4
6
H, HC(3)), 7.25 (t, J = 7.7 Hz, 3 H, HC(4)), 4.18 (t, J = 8.8 Hz, 3
Calcd for C H O Cl (210.66): C, 62.72; H, 5.26; Cl, 16.83. Found:
11
11
2
H, HC(5, 9, 10)), 2.35−2.25 (m, 4 H, HC(6, 7, 8, 11)), 1.76 (t, J =
C, 62.37; H, 5.28; Cl, 16.91.
1
10.8 Hz, 3 H, HC(6′, 8′, 11′)); TLC R 0.48 (hexane/EtOAc, 19:1)
Data for 24: H NMR (500 MHz, CDCl ) δ 7.52−7.30 (m, 5 H,
f
3
[
UV, I ].
HC(aryl)), 5.05 (d, J = 5.7 Hz, 1 H, HC(6)), 4.85 (td, J = 7.1, 5.8 Hz,
2
Data for (2R,6R,7S)-2,6,7-triphenylquinuclidine (19): 1H NMR
1
H, HC(5)), 2.60−2.44 (m, 2 H, H C(3)), 2.42−2.21 (m, 2 H,
2
13 1
(400 MHz, CDCl ) δ 7.76 (d, J = 7.5 Hz, 2 H, HC(aryl)), 7.39 (t, J =
H C(4)); C{ H} NMR (126 MHz, CDCl ) δ 176.3 (C(2)), 136.5
3
2
3
7
.5 Hz, 2 H), 7.25 (t, J = 8.5 Hz, 3 H, HC(aryl)), 7.01 (d, J = 7.1 Hz, 2
(
(
(
C(7)), 129.2 (C(10)), 128.9 (C(9)), 128.0 (C(8)), 82.1 (C(5)), 64.2
C(6)), 28.4 (C(3)), 24.3 (C(4)); IR (neat, cm ) 3546 (w), 2928
−1
H, HC(aryl)), 6.96−6.74 (m, 6 H, HC(aryl)), 4.44 (dd, J = 10.8, 4.4
Hz, 1 H, HC(9/10)), 4.37 (t, J = 8.7 Hz, 1 H, HC(9/10)), 3.88 (t, J =
w), 1776 (s, γ-lactone CO stretch), 1495 (w), 1454 (m), 1419 (w),
9
.6 Hz, 1 H, HC(5)), 2.38 (s, 1 H, HC(7)), 2.30 (m, 2 H, HC(8, 11)),
1
5
331 (w), 1173 (s), 1027 (m), 910 (m), 838 (w), 750 (w), 700 (m),
13
1
+
+
37
+
1.98 (m, 9.6 Hz, 4 H, HC(6, 8′, 11′)); C{ H} NMR (126 MHz,
33 (w); MS (EI , Quad, 70 eV) 212.1 (4, M , Cl), 210.1 (10, M ,
3
5
+
CDCl ) δ 144.3 (C(1)), 143.7 (C(1′)), 142.1 C(1″), 129.6, 128.2,
Cl), 125.0 (17), 114.9 (9), 85.1 (100); HRMS (ES , TOF) m/z
3
1
27.3, 127.2, 126.8, 126.7, 126.6 (C(2/3/4)), 126.3 (C(4′)), 124.8
calcd for C H O Cl, 211.0526, found 211.0532; TLC R 0.22
11
12
2
f
(
3
3
C(4″)), 63.1 (C(9/10)), 62.4 (C(9/10)), 51.7 (C(5)), 32.6 (C(6)),
(
hexanes/EtOAc 3:1) [UV, KMnO4].
1.4 (C(8/11)), 29.5 (C(8/11)), 24.4 (C(7)); IR (neat) 3058 (w),
026 (w), 2929 (w), 2865 (w), 1684 (w), 1601 (w), 1493 (w), 1466
(w), 1447 (w), 1337 (m), 1299 (w), 1202 (w), 1179 (w), 1074 (w),
1
043 (w), 984 (m), 908 (w), 841 (w), 825 (w), 805 (w), 788 (w), 741
+
(s), 692 (s), 649 (w), 612 (w), 592 (w), 550 (w); LR MS (EI , 70 eV)
+
+
3
40.2.; HR MS (EI , [M + H] ) m/z calcd for C H N 340.2065,
25 26
found 340.2065. CSP-HPLC: (R,R,S)-19, t 9.71 min (99%); (S,S,R)-
R
1
9, tR 12.24 min (1%) (NP-HPLC, CHIRALPAK OJH, 98.0:2.0
General Procedure: Chlorolactonization of 8 with 1-CBT in
the Presence of (DHQD) PHAL. Preparation of rel-(5R,6S)-5-
hexane/i-PrOH, 0.5 mL/min, 210 nm, 22 °C); [α] −90.25 (22 °C, c
= 1.3, THF).
D
2
Chlorotetrahydro-6-phenyl-2H-pyran-2-one (9). A 5 mm, oven-
J
J. Org. Chem. XXXX, XXX, XXX−XXX